Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action
about
sameAs
Gold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activitiesSynthesis and biophysical properties of C5-functionalized LNA (locked nucleic acid).C5-alkynyl-functionalized α-L-LNA: synthesis, thermal denaturation experiments and enzymatic stabilityOrganometallic anticancer compoundsCobalt derivatives as promising therapeutic agents5-Alkynyl-2'-deoxyuridines: chromatography-free synthesis and cytotoxicity evaluation against human breast cancer cellsNew trends for metal complexes with anticancer activityCurrent applications and future potential for bioinorganic chemistry in the development of anticancer drugs.Anticancer activity of metal complexes: involvement of redox processes.Organometallic compounds: an opportunity for chemical biology?The biological activity of Zeise's salt and its derivatives.Gold(I) thiotetrazolates as thioredoxin reductase inhibitors and antiproliferative agents.Synthesis and structure-activity relationship study of organometallic bioconjugates of the cyclic octapeptide octreotate.The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells.A novel water soluble ligand bridged cobalt(II) coordination polymer of 2-oxo-1,2-dihydroquinoline-3-carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity.Synthesis, characterisation and biological evaluation of copper and silver complexes based on acetylsalicylic acid.From catalysts to bioactive organometallics: do Grubbs catalysts trigger biological effects?Cellular selectivity and biological impact of cytotoxic rhodium(III) and iridium(III) complexes containing methyl-substituted phenanthroline ligands.Metallo-nucleosides: synthesis and biological evaluation of hexacarbonyl dicobalt 5-alkynyl-2'-deoxyuridines.Evaluation of arene ruthenium(II) N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing biomolecules.A chemical-biological evaluation of rhodium(I) N-heterocyclic carbene complexes as prospective anticancer drugs.Kinetico-mechanistic studies of substitution reactions on cross-bridged cyclen Co(III) complexes with nucleosides and nucleotides.Synthesis and cytotoxicity of a cobaltcarbonyl-alkyne enkephalin bioconjugate.The role of hydroxo-bridged dinuclear species and the influence of "innocent" buffers in the reactivity of cis-[Co(III)(cyclen)(H₂O)₂]³⁺ and [Co(III)(tren)(H₂O)₂]³⁺ complexes with biologically relevant ligands at physiological pH.Coordination-Driven Self-Assembly and Anticancer Potency Studies of Ruthenium-Cobalt-Based Heterometallic Rectangles.Inhibitory effects of different substituted transition metal-based krebs-type sandwich structures on human hepatocellular carcinoma cells.Targeted photodynamic therapy in visible light using BODIPY-appended copper(ii) complexes of a vitamin B6 Schiff base.Antileukemic activity and cellular effects of rhodium(III) crown thiaether complexes.Synthesis, characterization, and in vitro antiproliferative activity of [salophene]platinum(II) complexes.Organometallic Nucleosides: Synthesis and Biological Evaluation of Substituted Dicobalt Hexacarbonyl 2'-Deoxy-5-oxopropynyluridines.Synthesis and Biological Evaluation of Zeise's Salt Derivatives with Acetylsalicylic Acid Substructure.Synthesis, Spectroscopic, Anticancer, and Antimicrobial Properties of Some Metal(II) Complexes of (Substituted) Nitrophenol Schiff BaseBis(aryl)acenaphthenequinonediimine Substituent Effect on the Properties and Coordination Environment of Ligands and Their Bis-Chelate AgIComplexes
P2860
Q28543014-79D808D8-FFD1-43B0-A890-F4ADEB99B07CQ33725529-FCC4E839-BB30-46E8-837A-8FCB0391E038Q33725585-19F4EF90-F365-473B-97C7-21B950F4A8F4Q34476685-A0AAB7A8-9E9F-478D-ADBF-398605C5C23CQ36756033-1162BB0D-DF68-46D8-BCFF-CF80958CB77CQ36960377-CADE4BF3-2E50-4C86-9669-6409E152578AQ37044080-D0389CD6-92BD-460A-AD2C-044095CF2F4AQ37603642-B81864C8-F657-42C2-A0BC-BCB84B7EEB9FQ37833099-42DC6BAC-5ACF-4343-9E11-BAA879713424Q38012429-A5C29964-A9D7-404D-ABD6-964BDBA578DEQ38918301-D3A45D62-B15D-4DEB-A3A7-62C369D98069Q38938797-631E7014-1B2F-4827-ABCF-A39B3738383EQ39064228-9631FA6E-773F-4948-B015-03E12822EAAAQ39093077-D5D70710-B575-4A3C-B598-6939AE96063CQ39392668-137DAC36-8751-4DFB-AE90-FF5503E010BAQ39460986-4147EB8C-65C9-4576-819C-A591474938E9Q39477359-7BAFCA6C-3EE6-4A68-9EE7-6410DA9446B1Q39588751-A75D2380-CB51-45D5-8395-B3AC294BE6CFQ40036405-3BC6E114-1045-4D49-BBB4-F28029D2B0D9Q44548288-797E53F0-092A-44C5-A1DE-18859202203BQ45990319-B81E6511-F3C2-4201-803D-1AE47BD08683Q46656488-8FED6EA5-46AD-4BF8-B29D-871800740950Q46842266-F01F07DA-F57A-4CFF-AF56-7F75F72A7C87Q46880869-0A203167-466F-4679-B3F5-36611BE804B5Q48053815-396567CC-0C4F-4060-8CB2-1444A2A62E6EQ48185356-684910BC-B1D9-4136-B00C-CDB5A6E121C4Q49694160-92F3C651-0271-43A5-97B7-F2D91CF853ABQ51551365-235BC56B-3FEF-4C5D-96A3-07B37415B6C0Q52876809-70995D88-6735-4298-B36F-C45314E3FC30Q55309535-CB0D63DE-CF3D-4FEF-9274-8518B5758485Q55608069-CA9F4191-80EE-4E4A-B3AC-388EB3088F98Q58704562-6D39C6BD-D097-4FB5-B2ED-19E3731E3B17Q58834246-EFE034E2-35B9-4A91-AA08-77EF3A37D0FC
P2860
Antitumor-active cobalt-alkyne complexes derived from acetylsalicylic acid: studies on the mode of drug action
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Antitumor-active cobalt-alkyne ...... ies on the mode of drug action
@ast
Antitumor-active cobalt-alkyne ...... ies on the mode of drug action
@en
Antitumor-active cobalt-alkyne ...... ies on the mode of drug action
@nl
type
label
Antitumor-active cobalt-alkyne ...... ies on the mode of drug action
@ast
Antitumor-active cobalt-alkyne ...... ies on the mode of drug action
@en
Antitumor-active cobalt-alkyne ...... ies on the mode of drug action
@nl
prefLabel
Antitumor-active cobalt-alkyne ...... ies on the mode of drug action
@ast
Antitumor-active cobalt-alkyne ...... ies on the mode of drug action
@en
Antitumor-active cobalt-alkyne ...... ies on the mode of drug action
@nl
P2093
P356
P1476
Antitumor-active cobalt-alkyne ...... ies on the mode of drug action
@en
P2093
Brigitte Kircher
Kathrin Schmidt
Petra Schumacher
Ronald Gust
P304
P356
10.1021/JM049326Z
P407
P577
2005-01-01T00:00:00Z